Validation of a Contemporary Five-tiered Gleason Grade Grouping Using Population-based Data

Area of Science:

• Urology
• Oncology
• Cancer Research

Background:

• The Gleason score is a key prognostic factor in prostate cancer.
• A new five-tiered Gleason grade grouping (GGG) system has been proposed to refine prognostication.
• Accurate prediction of prostate cancer-specific mortality (PCSM) is crucial for treatment planning.

Purpose of the Study:

• To evaluate the predictive capability of the proposed five-tiered Gleason grade grouping (GGG) system for prostate cancer-specific mortality (PCSM).
• To assess the GGG system's performance across diverse patient populations and treatment modalities.

Main Methods:

• Population-based study utilizing the Surveillance, Epidemiology, and End Results (SEER) database.
• Inclusion of 331,320 prostate cancer patients diagnosed between January 2006 and December 2012.
• Application of the Fine and Gray proportional hazards model for subdistributions to quantify PCSM risk.

Main Results:

• The risk of PCSM demonstrated a significant increase with each increment in the GGG.
• For radical prostatectomy patients, adjusted hazard ratios for PCSM increased from 1.13 (GGG2) to 10.92 (GGG5) compared to GGG1.
• Consistent predictive patterns were observed irrespective of primary treatment or clinical stage.

Conclusions:

• The five-tiered Gleason grade grouping system is a robust predictor of prostate cancer-specific mortality.
• The GGG system's predictive accuracy is maintained across different treatment strategies and clinical stages.
• This validated grading system can significantly aid in guiding clinical treatment decisions for prostate cancer.